AIM: Cytokine production during hemorrhagic shock (HS) could affect cardiac function during the hours after resuscitation. Visfatin is a recently described protein that functions both as a proinflammatory plasma cytokine and an intracellular enzyme within the nicotinamide adenine dinucleotide (NAD(+)) salvage pathway. We developed a mouse model of HS to study the effect of therapeutic hypothermia (TH) on hemodynamic outcomes and associated plasma and tissue visfatin content. METHODS: Mice were bled and maintained at a mean arterial pressure (MAP) of 35 mmHg. After 30 min, animals (n=52) were randomized to normothermia (NT, 37+/-0.5 degrees C) or TH (33+/-0.5 degrees C) followed by rewarming at 60 min following resuscitation. After 90 min of HS (S90), mice were resuscitated and monitored for 180 min (R180). Visfatin, interleukin 6 (IL-6), keratinocyte-derived chemokine (KC), tumor necrosis factor-alpha (TNF-alpha), and myoglobin were measured by ELISA. RESULTS: Compared to NT, TH animals exhibited improved R180 survival (23/26 [88.5%] vs. 13/26 [50%]; p=0.001). Plasma visfatin, IL-6, KC, and TNF-alpha increased by S90 in both groups (p<0.05). TH attenuated S90 plasma visfatin and, after rewarming, decreased R180 plasma IL-6, KC, and myoglobin (p<0.05) relative to NT. Heart and gut KC increased at S90 while IL-6 increases were delayed until R180 (p<0.05). NT produced sustained elevations of myocardial KC but decreased visfatin by R180, effects abrogated by TH (p<0.05). CONCLUSIONS: In a mouse model of HS, TH improves hemodynamics and alters plasma and tissue proinflammatory cytokines including the novel cytokine visfatin. TH modulation of cytokines may attenuate cardiac dysfunction following HS. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
AIM: Cytokine production during hemorrhagic shock (HS) could affect cardiac function during the hours after resuscitation. Visfatin is a recently described protein that functions both as a proinflammatory plasma cytokine and an intracellular enzyme within the nicotinamide adenine dinucleotide (NAD(+)) salvage pathway. We developed a mouse model of HS to study the effect of therapeutic hypothermia (TH) on hemodynamic outcomes and associated plasma and tissue visfatin content. METHODS:Mice were bled and maintained at a mean arterial pressure (MAP) of 35 mmHg. After 30 min, animals (n=52) were randomized to normothermia (NT, 37+/-0.5 degrees C) or TH (33+/-0.5 degrees C) followed by rewarming at 60 min following resuscitation. After 90 min of HS (S90), mice were resuscitated and monitored for 180 min (R180). Visfatin, interleukin 6 (IL-6), keratinocyte-derived chemokine (KC), tumor necrosis factor-alpha (TNF-alpha), and myoglobin were measured by ELISA. RESULTS: Compared to NT, TH animals exhibited improved R180 survival (23/26 [88.5%] vs. 13/26 [50%]; p=0.001). Plasma visfatin, IL-6, KC, and TNF-alpha increased by S90 in both groups (p<0.05). TH attenuated S90 plasma visfatin and, after rewarming, decreased R180 plasma IL-6, KC, and myoglobin (p<0.05) relative to NT. Heart and gut KC increased at S90 while IL-6 increases were delayed until R180 (p<0.05). NT produced sustained elevations of myocardial KC but decreased visfatin by R180, effects abrogated by TH (p<0.05). CONCLUSIONS: In a mouse model of HS, TH improves hemodynamics and alters plasma and tissue proinflammatory cytokines including the novel cytokine visfatin. TH modulation of cytokines may attenuate cardiac dysfunction following HS. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
Authors: Benjamin S Abella; Danhong Zhao; Jason Alvarado; Kim Hamann; Terry L Vanden Hoek; Lance B Becker Journal: Circulation Date: 2004-05-24 Impact factor: 29.690
Authors: Karen D Fairchild; Ishwar S Singh; Sandip Patel; Beth E Drysdale; Rose M Viscardi; Lisa Hester; Heather M Lazusky; Jeffrey D Hasday Journal: Am J Physiol Cell Physiol Date: 2004-04-07 Impact factor: 4.249
Authors: Xianren Wu; Jason Stezoski; Peter Safar; Anthony Bauer; Andreas Tuerler; Nicholas Schwarz; Rainer Kentner; Wilhelm Behringer; Patrick M Kochanek; Samuel A Tisherman Journal: Crit Care Med Date: 2003-01 Impact factor: 7.598
Authors: Fabrizio Montecucco; Inga Bauer; Vincent Braunersreuther; Santina Bruzzone; Alexander Akhmedov; Thomas F Lüscher; Timo Speer; Alessandro Poggi; Elena Mannino; Graziano Pelli; Katia Galan; Maria Bertolotto; Sébastien Lenglet; Anna Garuti; Christophe Montessuit; René Lerch; Corinne Pellieux; Nicolas Vuilleumier; Franco Dallegri; Jacqueline Mage; Carlos Sebastian; Raul Mostoslavsky; Angèle Gayet-Ageron; Franco Patrone; François Mach; Alessio Nencioni Journal: Antioxid Redox Signal Date: 2012-05-14 Impact factor: 8.401
Authors: Jing Li; Huashan Wang; Qiang Zhong; Xiangdong Zhu; Sy-Jou Chen; Yuanyu Qian; Jim Costakis; Gabrielle Bunney; David G Beiser; Alan R Leff; E Douglas Lewandowski; J Michael ÓDonnell; Terry L Vanden Hoek Journal: Am J Physiol Heart Circ Physiol Date: 2015-03-20 Impact factor: 4.733
Authors: Michael Frink; Sascha Flohé; Martijn van Griensven; Philipp Mommsen; Frank Hildebrand Journal: Mediators Inflamm Date: 2012-03-13 Impact factor: 4.711
Authors: Sara M Camp; Ermelinda Ceco; Carrie L Evenoski; Sergei M Danilov; Tong Zhou; Eddie T Chiang; Liliana Moreno-Vinasco; Brandon Mapes; Jieling Zhao; Gamze Gursoy; Mary E Brown; Djanybek M Adyshev; Shahid S Siddiqui; Hector Quijada; Saad Sammani; Eleftheria Letsiou; Laleh Saadat; Mohammed Yousef; Ting Wang; Jie Liang; Joe G N Garcia Journal: Sci Rep Date: 2015-08-14 Impact factor: 4.379